CBI’s 2nd Annual Commercialization and Market Access Congress
- Philadelphia, Pennsylvania
Industry's Senior Commercial Executives Convene this December in Philadelphia!
Join executives responsible for ensuring the commercial success of new drugs, devices and diagnostics at CBI’s 2nd Annual Commercialization and Market Access Congress. With increased generic competition, growing pressure to align product price with value and a trend toward reductions in marketing and sales forces, companies must consider factors that make a product commercially viable at every step of development and launch. How is the U.S. marketplace impacted by healthcare reform and how can companies position themselves for success in a shifting market? What information do payers need to make a positive reimbursement decision? How should internal product teams interact with clinical development and external thought leaders to pave the way for an effective launch? These and many other questions are addressed in this interactive forum. Building off our successful premier event, CMAC 2011 will be co-located with the 7th Annual Biopharmaceutical Trade & Channel Strategies, increasing your networking and benchmarking opportunities!
Program highlights include:
Choose from two pre-conference workshops
- Simulate Product Commercialization
Hone Your Reimbursement Strategy
- Move between two focused tracks – Pre-Launch Planning and Post-Launch Initiatives
Leverage networking opportunities in breaks with attendees from CBI’s Biopharmaceutical Trade & Channel Strategies
Don’t miss the commercialization and market access event of the year!
Virtual Polling and Live Twitter Feed Throughout the Congress for Real-Time Benchmarking!
2010 Attendee Breakdown by Title